Cojutti, Pier Giorgio; Maximova, Natalia; Schillani, Giulia; Hope, William; Pea, Federico, Population pharmacokinetics of continuous-infusion ceftazidime in febrile neutropenic children undergoing HSCT: implications for target attainment for empirical treatment against Pseudomonas aeruginosa, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 1648 - 1655 [articolo]
Cojutti P.G.; Merelli M.; Bassetti M.; Pea F., Proactive therapeutic drug monitoring (TDM) may be helpful in managing long-term treatment with linezolid safely: Findings from a monocentric, prospective, open-label, interventional study, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2019, 74, pp. 3588 - 3595 [articolo]
Crass R.L.; Cojutti P.G.; Pai M.P.; Pea F., Reappraisal of linezolid dosing in renal impairment to improve safety, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2019, 63, pp. 1 - 9 [articolo]
Cojutti P.G.; Merelli M.; Allegri L.; Damante G.; Bassetti M.; Pea F., Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2019, 85, pp. 266 - 269 [articolo]
Righi, Elda; Carnelutti, Alessia; Baccarani, Umberto; Sartor, Assunta; Cojutti, Piergiorgio; Bassetti, Matteo; Pea, Federico, Treatment of Candida Infections with Fluconazole in Adult Liver Transplant Recipients: Is TDM-guided Dosing Adaptation Helpful?, «TRANSPLANT INFECTIOUS DISEASE», 2019, 21, pp. e13113 - - [articolo]
Cojutti P.G.; Candoni A.; Lazzarotto D.; Rabassi N.; Fanin R.; Hope W.; Pea F., Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies, «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 84, pp. 2544 - 2550 [articolo]
Cojutti P.G.; Merelli M.; De Stefanis P.; Fregonese C.; Lucchese F.; Bassetti M.; Pea F., Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1671 - 1672 [replica/breve intervento]
Cojutti P.G.; Barbarino C.; De Monte A.; Hope W.; Pea F., Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1091 - 1092 [articolo]
Cojutti P.; Sartor A.; Bassetti M.; Scarparo C.; Pea F., Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?, «JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE», 2018, 14, pp. 238 - 241 [articolo]
Cojutti P.; Pai M.P.; Pea F., Population Pharmacokinetics and Dosing Considerations for the Use of Linezolid in Overweight and Obese Adult Patients, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 989 - 1000 [articolo]
Cojutti P.G.; Lugano M.; Righi E.; Della Rocca G.; Bassetti M.; Hope W.; Pea F., Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp, «EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY», 2018, 74, pp. 1449 - 1459 [articolo]
Tangden T.; Cojutti P.G.; Roberts J.A.; Pea F., Valganciclovir Pharmacokinetics in Patients Receiving Oral Prophylaxis Following Kidney Transplantation and Model-Based Predictions of Optimal Dosing Regimens, «CLINICAL PHARMACOKINETICS», 2018, 57, pp. 1399 - 1405 [articolo]
Pea F.; Cojutti P.G.; Baraldo M., A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?, «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2017, 121, pp. 303 - 308 [articolo]
Bassetti M.; Pecori D.; Cojutti P.; Righi E.; Pea F., Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2017, 13, pp. 1193 - 1200 [articolo]
Cojutti P.; Giangreco M.; Isola M.; Pea F., Limited sampling strategies for determining the area under the plasma concentration–time curve for isoniazid might be a valuable approach for optimizing treatment in adult patients with tuberculosis, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2017, 50, pp. 23 - 28 [articolo]
